Related Experiment Video
Updated: Dec 30, 2025

04:04
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
316
Extreme Lateral Transodontoid Approach for Resection of Clival Chordoma: 2-Dimensional Operative Video.
Evan J Joyce1, Michael A Cohen1, Winson Ho1
1Department of Neurosurgery, Clinical Neurosciences Center, University of Utah, Salt Lake City, Utah.
Operative Neurosurgery (Hagerstown, Md.)
|January 17, 2020
Summary
A rare chordoma in a 15-year-old girl caused severe brainstem compression. Surgical resection via the extreme lateral transodontoid approach achieved gross-total removal, with planned proton beam therapy for optimal outcomes.
Area of Science:
- Neurosurgery
- Oncology
- Radiology
Background:
- Chordomas are rare, slow-growing bone tumors arising from notochordal remnants.
- Craniovertebral junction (CVJ) chordomas present diagnostic and surgical challenges due to proximity to critical neurovascular structures.
- Early diagnosis and complete resection are crucial for favorable outcomes in CVJ chordomas.
Observation:
- A 15-year-old female presented with nasal obstruction, dysphagia, weight loss, and hoarse voice.
- Imaging revealed an erosive clival and occipital condyle lesion with significant brainstem compression at the CVJ.
- Biopsy confirmed chordoma; the tumor extended into the retropharyngeal space.
Findings:
- Complete tumor resection was achieved using the left extreme lateral transodontoid (ELTO) approach.
- This approach provided bilateral exposure of the ventral CVJ and retropharyngeal space for single-stage resection.
- Postoperative MRI confirmed gross-total resection and brainstem decompression; proton beam therapy is planned.
Implications:
- The ELTO approach is a viable option for complex CVJ chordomas, enabling complete resection.
- Multidisciplinary management, including surgery and adjuvant radiotherapy, is essential for chordoma treatment.
- Further research into optimizing surgical techniques and adjuvant therapies for CVJ chordomas is warranted.

